Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma

• Status: Recruiting
• Trial end date: 2022-12-01

Summary

This study is an open, multi-center phase I/II clinical study.

• Phase: Phase 1/Phase 2

Details

• Lead Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd